Global Subcutaneous Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 114
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Subcutaneous Vaccine Adjuvants market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Subcutaneous Vaccine Adjuvants is used for Subcutaneous injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Subcutaneous Vaccine Adjuvants industry chain, the market status of Research Applications (Infectious Diseases, Cancer), Commercial Applications (Infectious Diseases, Cancer), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Subcutaneous Vaccine Adjuvants.
Regionally, the report analyzes the Subcutaneous Vaccine Adjuvants markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Subcutaneous Vaccine Adjuvants market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Subcutaneous Vaccine Adjuvants market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Subcutaneous Vaccine Adjuvants industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Infectious Diseases, Cancer).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Subcutaneous Vaccine Adjuvants market.
Regional Analysis: The report involves examining the Subcutaneous Vaccine Adjuvants market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Subcutaneous Vaccine Adjuvants market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Subcutaneous Vaccine Adjuvants:
Company Analysis: Report covers individual Subcutaneous Vaccine Adjuvants manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Subcutaneous Vaccine Adjuvants This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Research Applications, Commercial Applications).
Technology Analysis: Report covers specific technologies relevant to Subcutaneous Vaccine Adjuvants. It assesses the current state, advancements, and potential future developments in Subcutaneous Vaccine Adjuvants areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Subcutaneous Vaccine Adjuvants market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Subcutaneous Vaccine Adjuvants market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Infectious Diseases
Cancer
Others
Market segment by Application
Research Applications
Commercial Applications
Major players covered
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
GSK
Dynavax Technologies
Novavax
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Subcutaneous Vaccine Adjuvants product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Subcutaneous Vaccine Adjuvants, with price, sales, revenue and global market share of Subcutaneous Vaccine Adjuvants from 2019 to 2024.
Chapter 3, the Subcutaneous Vaccine Adjuvants competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Subcutaneous Vaccine Adjuvants breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Subcutaneous Vaccine Adjuvants market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Subcutaneous Vaccine Adjuvants.
Chapter 14 and 15, to describe Subcutaneous Vaccine Adjuvants sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Subcutaneous Vaccine Adjuvants
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Subcutaneous Vaccine Adjuvants Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Infectious Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Subcutaneous Vaccine Adjuvants Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Research Applications
1.4.3 Commercial Applications
1.5 Global Subcutaneous Vaccine Adjuvants Market Size & Forecast
1.5.1 Global Subcutaneous Vaccine Adjuvants Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Subcutaneous Vaccine Adjuvants Sales Quantity (2019-2030)
1.5.3 Global Subcutaneous Vaccine Adjuvants Average Price (2019-2030)
2.1 Agenus
2.1.1 Agenus Details
2.1.2 Agenus Major Business
2.1.3 Agenus Subcutaneous Vaccine Adjuvants Product and Services
2.1.4 Agenus Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Agenus Recent Developments/Updates
2.2 Croda International
2.2.1 Croda International Details
2.2.2 Croda International Major Business
2.2.3 Croda International Subcutaneous Vaccine Adjuvants Product and Services
2.2.4 Croda International Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Croda International Recent Developments/Updates
2.3 Seppic
2.3.1 Seppic Details
2.3.2 Seppic Major Business
2.3.3 Seppic Subcutaneous Vaccine Adjuvants Product and Services
2.3.4 Seppic Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Seppic Recent Developments/Updates
2.4 OZ Biosciences
2.4.1 OZ Biosciences Details
2.4.2 OZ Biosciences Major Business
2.4.3 OZ Biosciences Subcutaneous Vaccine Adjuvants Product and Services
2.4.4 OZ Biosciences Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 OZ Biosciences Recent Developments/Updates
2.5 Phibro Animal Health
2.5.1 Phibro Animal Health Details
2.5.2 Phibro Animal Health Major Business
2.5.3 Phibro Animal Health Subcutaneous Vaccine Adjuvants Product and Services
2.5.4 Phibro Animal Health Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Phibro Animal Health Recent Developments/Updates
2.6 Associated British Foods
2.6.1 Associated British Foods Details
2.6.2 Associated British Foods Major Business
2.6.3 Associated British Foods Subcutaneous Vaccine Adjuvants Product and Services
2.6.4 Associated British Foods Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Associated British Foods Recent Developments/Updates
2.7 InvivoGen
2.7.1 InvivoGen Details
2.7.2 InvivoGen Major Business
2.7.3 InvivoGen Subcutaneous Vaccine Adjuvants Product and Services
2.7.4 InvivoGen Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 InvivoGen Recent Developments/Updates
2.8 Merck KGaA
2.8.1 Merck KGaA Details
2.8.2 Merck KGaA Major Business
2.8.3 Merck KGaA Subcutaneous Vaccine Adjuvants Product and Services
2.8.4 Merck KGaA Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Merck KGaA Recent Developments/Updates
2.9 CSL Limited
2.9.1 CSL Limited Details
2.9.2 CSL Limited Major Business
2.9.3 CSL Limited Subcutaneous Vaccine Adjuvants Product and Services
2.9.4 CSL Limited Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 CSL Limited Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Subcutaneous Vaccine Adjuvants Product and Services
2.10.4 GSK Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 GSK Recent Developments/Updates
2.11 Dynavax Technologies
2.11.1 Dynavax Technologies Details
2.11.2 Dynavax Technologies Major Business
2.11.3 Dynavax Technologies Subcutaneous Vaccine Adjuvants Product and Services
2.11.4 Dynavax Technologies Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Dynavax Technologies Recent Developments/Updates
2.12 Novavax
2.12.1 Novavax Details
2.12.2 Novavax Major Business
2.12.3 Novavax Subcutaneous Vaccine Adjuvants Product and Services
2.12.4 Novavax Subcutaneous Vaccine Adjuvants Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Novavax Recent Developments/Updates
3.1 Global Subcutaneous Vaccine Adjuvants Sales Quantity by Manufacturer (2019-2024)
3.2 Global Subcutaneous Vaccine Adjuvants Revenue by Manufacturer (2019-2024)
3.3 Global Subcutaneous Vaccine Adjuvants Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Subcutaneous Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Subcutaneous Vaccine Adjuvants Manufacturer Market Share in 2023
3.4.2 Top 6 Subcutaneous Vaccine Adjuvants Manufacturer Market Share in 2023
3.5 Subcutaneous Vaccine Adjuvants Market: Overall Company Footprint Analysis
3.5.1 Subcutaneous Vaccine Adjuvants Market: Region Footprint
3.5.2 Subcutaneous Vaccine Adjuvants Market: Company Product Type Footprint
3.5.3 Subcutaneous Vaccine Adjuvants Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Subcutaneous Vaccine Adjuvants Market Size by Region
4.1.1 Global Subcutaneous Vaccine Adjuvants Sales Quantity by Region (2019-2030)
4.1.2 Global Subcutaneous Vaccine Adjuvants Consumption Value by Region (2019-2030)
4.1.3 Global Subcutaneous Vaccine Adjuvants Average Price by Region (2019-2030)
4.2 North America Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030)
4.3 Europe Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030)
4.4 Asia-Pacific Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030)
4.5 South America Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030)
4.6 Middle East and Africa Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030)
5.1 Global Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2030)
5.2 Global Subcutaneous Vaccine Adjuvants Consumption Value by Type (2019-2030)
5.3 Global Subcutaneous Vaccine Adjuvants Average Price by Type (2019-2030)
6.1 Global Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2030)
6.2 Global Subcutaneous Vaccine Adjuvants Consumption Value by Application (2019-2030)
6.3 Global Subcutaneous Vaccine Adjuvants Average Price by Application (2019-2030)
7.1 North America Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2030)
7.2 North America Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2030)
7.3 North America Subcutaneous Vaccine Adjuvants Market Size by Country
7.3.1 North America Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2019-2030)
7.3.2 North America Subcutaneous Vaccine Adjuvants Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2030)
8.2 Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2030)
8.3 Europe Subcutaneous Vaccine Adjuvants Market Size by Country
8.3.1 Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2019-2030)
8.3.2 Europe Subcutaneous Vaccine Adjuvants Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Subcutaneous Vaccine Adjuvants Market Size by Region
9.3.1 Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Subcutaneous Vaccine Adjuvants Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2030)
10.2 South America Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2030)
10.3 South America Subcutaneous Vaccine Adjuvants Market Size by Country
10.3.1 South America Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2019-2030)
10.3.2 South America Subcutaneous Vaccine Adjuvants Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Subcutaneous Vaccine Adjuvants Market Size by Country
11.3.1 Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Subcutaneous Vaccine Adjuvants Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Subcutaneous Vaccine Adjuvants Market Drivers
12.2 Subcutaneous Vaccine Adjuvants Market Restraints
12.3 Subcutaneous Vaccine Adjuvants Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Subcutaneous Vaccine Adjuvants and Key Manufacturers
13.2 Manufacturing Costs Percentage of Subcutaneous Vaccine Adjuvants
13.3 Subcutaneous Vaccine Adjuvants Production Process
13.4 Subcutaneous Vaccine Adjuvants Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Subcutaneous Vaccine Adjuvants Typical Distributors
14.3 Subcutaneous Vaccine Adjuvants Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Subcutaneous Vaccine Adjuvants Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Subcutaneous Vaccine Adjuvants Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Agenus Basic Information, Manufacturing Base and Competitors
Table 4. Agenus Major Business
Table 5. Agenus Subcutaneous Vaccine Adjuvants Product and Services
Table 6. Agenus Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Agenus Recent Developments/Updates
Table 8. Croda International Basic Information, Manufacturing Base and Competitors
Table 9. Croda International Major Business
Table 10. Croda International Subcutaneous Vaccine Adjuvants Product and Services
Table 11. Croda International Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Croda International Recent Developments/Updates
Table 13. Seppic Basic Information, Manufacturing Base and Competitors
Table 14. Seppic Major Business
Table 15. Seppic Subcutaneous Vaccine Adjuvants Product and Services
Table 16. Seppic Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Seppic Recent Developments/Updates
Table 18. OZ Biosciences Basic Information, Manufacturing Base and Competitors
Table 19. OZ Biosciences Major Business
Table 20. OZ Biosciences Subcutaneous Vaccine Adjuvants Product and Services
Table 21. OZ Biosciences Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. OZ Biosciences Recent Developments/Updates
Table 23. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
Table 24. Phibro Animal Health Major Business
Table 25. Phibro Animal Health Subcutaneous Vaccine Adjuvants Product and Services
Table 26. Phibro Animal Health Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Phibro Animal Health Recent Developments/Updates
Table 28. Associated British Foods Basic Information, Manufacturing Base and Competitors
Table 29. Associated British Foods Major Business
Table 30. Associated British Foods Subcutaneous Vaccine Adjuvants Product and Services
Table 31. Associated British Foods Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Associated British Foods Recent Developments/Updates
Table 33. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 34. InvivoGen Major Business
Table 35. InvivoGen Subcutaneous Vaccine Adjuvants Product and Services
Table 36. InvivoGen Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. InvivoGen Recent Developments/Updates
Table 38. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 39. Merck KGaA Major Business
Table 40. Merck KGaA Subcutaneous Vaccine Adjuvants Product and Services
Table 41. Merck KGaA Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Merck KGaA Recent Developments/Updates
Table 43. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 44. CSL Limited Major Business
Table 45. CSL Limited Subcutaneous Vaccine Adjuvants Product and Services
Table 46. CSL Limited Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. CSL Limited Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK Subcutaneous Vaccine Adjuvants Product and Services
Table 51. GSK Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. GSK Recent Developments/Updates
Table 53. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
Table 54. Dynavax Technologies Major Business
Table 55. Dynavax Technologies Subcutaneous Vaccine Adjuvants Product and Services
Table 56. Dynavax Technologies Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Dynavax Technologies Recent Developments/Updates
Table 58. Novavax Basic Information, Manufacturing Base and Competitors
Table 59. Novavax Major Business
Table 60. Novavax Subcutaneous Vaccine Adjuvants Product and Services
Table 61. Novavax Subcutaneous Vaccine Adjuvants Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Novavax Recent Developments/Updates
Table 63. Global Subcutaneous Vaccine Adjuvants Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 64. Global Subcutaneous Vaccine Adjuvants Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Subcutaneous Vaccine Adjuvants Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 66. Market Position of Manufacturers in Subcutaneous Vaccine Adjuvants, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Subcutaneous Vaccine Adjuvants Production Site of Key Manufacturer
Table 68. Subcutaneous Vaccine Adjuvants Market: Company Product Type Footprint
Table 69. Subcutaneous Vaccine Adjuvants Market: Company Product Application Footprint
Table 70. Subcutaneous Vaccine Adjuvants New Market Entrants and Barriers to Market Entry
Table 71. Subcutaneous Vaccine Adjuvants Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Subcutaneous Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
Table 73. Global Subcutaneous Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
Table 74. Global Subcutaneous Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Subcutaneous Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Subcutaneous Vaccine Adjuvants Average Price by Region (2019-2024) & (US$/Unit)
Table 77. Global Subcutaneous Vaccine Adjuvants Average Price by Region (2025-2030) & (US$/Unit)
Table 78. Global Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Global Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Global Subcutaneous Vaccine Adjuvants Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Subcutaneous Vaccine Adjuvants Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Subcutaneous Vaccine Adjuvants Average Price by Type (2019-2024) & (US$/Unit)
Table 83. Global Subcutaneous Vaccine Adjuvants Average Price by Type (2025-2030) & (US$/Unit)
Table 84. Global Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
Table 85. Global Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
Table 86. Global Subcutaneous Vaccine Adjuvants Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Subcutaneous Vaccine Adjuvants Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Subcutaneous Vaccine Adjuvants Average Price by Application (2019-2024) & (US$/Unit)
Table 89. Global Subcutaneous Vaccine Adjuvants Average Price by Application (2025-2030) & (US$/Unit)
Table 90. North America Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
Table 91. North America Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
Table 92. North America Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
Table 93. North America Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
Table 94. North America Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
Table 95. North America Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
Table 96. North America Subcutaneous Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Subcutaneous Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
Table 99. Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
Table 100. Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
Table 101. Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
Table 102. Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
Table 103. Europe Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
Table 104. Europe Subcutaneous Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Subcutaneous Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
Table 107. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
Table 108. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
Table 109. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
Table 110. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
Table 111. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
Table 112. Asia-Pacific Subcutaneous Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Subcutaneous Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
Table 115. South America Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
Table 116. South America Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
Table 117. South America Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
Table 118. South America Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2019-2024) & (K Units)
Table 119. South America Subcutaneous Vaccine Adjuvants Sales Quantity by Country (2025-2030) & (K Units)
Table 120. South America Subcutaneous Vaccine Adjuvants Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Subcutaneous Vaccine Adjuvants Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2019-2024) & (K Units)
Table 123. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Type (2025-2030) & (K Units)
Table 124. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Region (2019-2024) & (K Units)
Table 127. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity by Region (2025-2030) & (K Units)
Table 128. Middle East & Africa Subcutaneous Vaccine Adjuvants Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Subcutaneous Vaccine Adjuvants Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Subcutaneous Vaccine Adjuvants Raw Material
Table 131. Key Manufacturers of Subcutaneous Vaccine Adjuvants Raw Materials
Table 132. Subcutaneous Vaccine Adjuvants Typical Distributors
Table 133. Subcutaneous Vaccine Adjuvants Typical Customers
List of Figures
Figure 1. Subcutaneous Vaccine Adjuvants Picture
Figure 2. Global Subcutaneous Vaccine Adjuvants Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Type in 2023
Figure 4. Infectious Diseases Examples
Figure 5. Cancer Examples
Figure 6. Others Examples
Figure 7. Global Subcutaneous Vaccine Adjuvants Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Application in 2023
Figure 9. Research Applications Examples
Figure 10. Commercial Applications Examples
Figure 11. Global Subcutaneous Vaccine Adjuvants Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Subcutaneous Vaccine Adjuvants Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Subcutaneous Vaccine Adjuvants Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Subcutaneous Vaccine Adjuvants Average Price (2019-2030) & (US$/Unit)
Figure 15. Global Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Subcutaneous Vaccine Adjuvants by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Subcutaneous Vaccine Adjuvants Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Subcutaneous Vaccine Adjuvants Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Subcutaneous Vaccine Adjuvants Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Subcutaneous Vaccine Adjuvants Average Price by Type (2019-2030) & (US$/Unit)
Figure 30. Global Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Subcutaneous Vaccine Adjuvants Average Price by Application (2019-2030) & (US$/Unit)
Figure 33. North America Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
Figure 53. China Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Subcutaneous Vaccine Adjuvants Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Subcutaneous Vaccine Adjuvants Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Subcutaneous Vaccine Adjuvants Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Subcutaneous Vaccine Adjuvants Market Drivers
Figure 74. Subcutaneous Vaccine Adjuvants Market Restraints
Figure 75. Subcutaneous Vaccine Adjuvants Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Subcutaneous Vaccine Adjuvants in 2023
Figure 78. Manufacturing Process Analysis of Subcutaneous Vaccine Adjuvants
Figure 79. Subcutaneous Vaccine Adjuvants Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Agenus Croda International Seppic OZ Biosciences Phibro Animal Health Associated British Foods InvivoGen Merck KGaA CSL Limited GSK Dynavax Technologies Novavax
Related Reports
04 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
